Results 11 to 20 of about 28,117 (245)

Clinical Factors Impacting Outcomes From Failed Trabeculectomy Leading to Glaucoma Drainage Device Implantation and Subsequent Penetrating Keratoplasty. [PDF]

open access: yesJ Glaucoma, 2023
Précis: We evaluated the factors that impacted time from glaucoma drainage implant (GDI) surgery to penetrating keratoplasty (PK) in eyes with previously clear corneas (ie, GDI-first sequence), and that specifically underwent a trabeculectomy before GDI ...
Chen JL   +8 more
europepmc   +2 more sources

36-Month Outcomes of Ahmed ClearPath® Glaucoma Drainage Device in Severe Primary Open Angle Glaucoma. [PDF]

open access: yesClin Ophthalmol
Purpose To evaluate the safety and effectiveness of the Ahmed ClearPath® (ACP) 250 mm2 glaucoma drainage device (GDD) in managing refractory primary open-angle glaucoma (POAG).
Boopathiraj N   +7 more
europepmc   +2 more sources

Anti-Scar Effects of Micropatterned Hydrogel after Glaucoma Drainage Device Implantation. [PDF]

open access: yesResearch (Wash D C)
Excessive fibrosis is the primary factor for the failure of glaucoma drainage device (GDD) implantation. Thus, strategies to suppress scar formation in GDD implantation are crucial.
Han Y   +11 more
europepmc   +2 more sources

A comparative study of cystoid macula edema following glaucoma drainage device surgery versus trabeculectomy. [PDF]

open access: yesInt Ophthalmol
Purpose To assess and compare the risk for development of cystoid macula edema (CME) after glaucoma drainage device (GDD) implantation versus conventional trabeculectomy with mitomycin (trab) for glaucoma.
Gietzelt C   +7 more
europepmc   +2 more sources

Surgical Outcomes of Glaucoma Drainage Device Implantation in Refractory Glaucoma Patients in Thailand. [PDF]

open access: yesClin Ophthalmol, 2022
Purpose To study the surgical outcomes of glaucoma drainage device (GDD) implantation in refractory glaucoma patients. Patients and Methods Retrospective chart review of glaucoma patients undergoing GDD implantation, Ahmed glaucoma valve (AGV), Baerveldt
Rojananuangnit K   +3 more
europepmc   +2 more sources

Evaluating the Safety and Efficacy of a Novel Glaucoma Drainage Device in High-Risk Adult Glaucoma Patients: A One-Year Pilot Study. [PDF]

open access: yesJ Clin Med
Background: We report on the 12-month safety and efficacy outcomes of a new non-valved glaucoma drainage device, the eyePlate-300 (Rheon Medical, Lausanne, Switzerland), in managing refractory glaucoma.
Ahmed F   +4 more
europepmc   +2 more sources

24-Month Outcomes of Ahmed ClearPath® Glaucoma Drainage Device for Refractory Glaucoma. [PDF]

open access: yesClin Ophthalmol, 2022
Purpose To describe the safety and efficacy of the Ahmed ClearPath® (ACP) 250 mm2 glaucoma drainage device (GDD) in the treatment of refractory primary open-angle glaucoma (POAG).
Dorairaj S   +4 more
europepmc   +2 more sources

Quality of life in glaucoma patients: Comparison of medical therapy, trabeculectomy, and glaucoma drainage device surgery. [PDF]

open access: yesIndian J Ophthalmol, 2022
Purpose: To compare the quality of life (QoL) in patients with glaucoma on medical therapy and after trabeculectomy and glaucoma drainage device (GDD) using vision, glaucoma, and surgery-specific questionnaires.
Muralidharan S   +3 more
europepmc   +2 more sources

The use of trypan blue to distinguish Pseudo-Seidel sign from lacrimal ductule versus glaucoma drainage device leakage [PDF]

open access: yesAmerican Journal of Ophthalmology Case Reports
Introduction: The superotemporal fornix location of the lacrimal gland ductule openings coincides with the typical locations of glaucoma drainage devices; as a result, a conjunctival fistula may look and behave like a lacrimal gland ductule.
Hamidah Mahmud   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy